Immune 3: Two epitopes, four serotypes, and a partridge in a pear tree
Immune
00:00
Dengvaxia trial outcomes and licensing
Vincent reviews phase III trial results, licensing, and later emergence of severe disease in vaccinees.
Play episode from 11:53
Transcript
